Apontis Pharma AG (APPH) — Tangible Net Worth Ratio
Apontis Pharma AG (APPH) has a Tangible Net Worth Ratio of 39.7% as of June 2025. This metric is calculated by deducting intangible assets (€19.08 Million) from net assets (€31.62 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of Apontis Pharma AG for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Apontis Pharma AG Tangible Net Worth Ratio (2018–2024)
This chart shows how Apontis Pharma AG's Tangible Net Worth Ratio has changed across 7 annual periods from 2018 to 2024. As of June 2025, the ratio stands at 39.7%, reflecting net assets of €31.62 Million with intangible assets of €19.08 Million EUR. Also explore Apontis Pharma AG (APPH) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Apontis Pharma AG (2018–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Apontis Pharma AG from 2018 to 2024, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Apontis Pharma AG worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 43.1% | €31.02 Million | €17.65 Million | €44.37 Million | ▲ +1.0 pp |
| 2023 | 42.0% | €30.26 Million | €17.54 Million | €57.46 Million | ▼ -19.1 pp |
| 2022 | 61.2% | €41.57 Million | €16.15 Million | €59.85 Million | ▼ -2.8 pp |
| 2021 | 63.9% | €40.71 Million | €14.69 Million | €54.13 Million | ▲ +390.6 pp |
| 2020 | -326.7% | €3.46 Million | €14.76 Million | €29.69 Million | ▼ -89.4 pp |
| 2019 | -237.3% | €4.64 Million | €15.65 Million | €30.59 Million | ▼ -121.9 pp |
| 2018 | -115.4% | €7.03 Million | €15.15 Million | €34.84 Million | — |